Author： Robertson David M Oehler Martin K
Publisher： Future Medicine
ISSN： 1745-5057
Source： Women's Health, Vol.1, Iss.1, 2005-07, pp. : 51-57
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Biomarker discovery in ovarian cancer
By Tung Celestine S Wong Kwong-Kwok Mok Samuel C
Women's Health, Vol. 4, Iss. 1, 2008-01 ,pp. :
Access to resources
Recommend
Role of gemcitabine in the treatment of ovarian cancer
By AbuShahin Fadi Rose Peter G
Women's Health, Vol. 3, Iss. 3, 2007-05 ,pp. :
Ovarian cancer biomarker screening: still too early to tell
Women's Health, Vol. 6, Iss. 4, 2010-07 ,pp. :
An emerging role of PARK2 in cancer
By Xu Liang Lin De-chen Yin Dong Koeffler H.
Journal of Molecular Medicine, Vol. 92, Iss. 1, 2014-01 ,pp. :
Role of secondary cytoreduction in recurrent ovarian cancer
By Barlin Joyce N Bristow Robert E Chi Dennis S
Therapy, Vol. 7, Iss. 3, 2010-05 ,pp. :